MNHFF yields 2.13% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, MNHFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MNHFF + PFE for your $10,000?
Mayr-Melnhof Karton AG manufactures and sells cartonboard and folding cartons in Europe and internationally. It operates in two segments, MM Board & Paper and MM Packaging. The MM Board & Paper segment manufactures and markets various grades of cartonboard products, such as coated cartonboard produced from paper for recycling, as well as virgin fiber based cartonboard. Its cartonboard is used as a raw material in the production of folding carton packaging; and for food packaging, as well as packaging for household and hygiene products. This segment primarily serves printing businesses in the fragmented folding carton industry. The MM Packaging segment processes cartonboard into folding cartons primarily for food industry, as well as for other consumer goods industries; and for the markets of packages for cigarettes, detergents, pharmaceuticals, personal care, and luxury products. Mayr-Melnhof Karton AG was founded in 1950 and is based in Vienna, Austria.
Full MNHFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.